Beyond Awareness: Putting patients at the heart of the medical cannabis conversation
From challenging stigma and improving access to supporting patients beyond the prescription, CIC’s recent broadcast explored the issues shaping medical cannabis care in the UK.
On 20 October 2026, the Cannabis Industry Council (CIC) brought together patients, clinicians, patient organisations and industry representatives for Beyond Awareness: Patient Choice, Safety & Improved Quality of Life, broadcast live from BRITISH CANNABIS HQ in Wokingham.
Delivered in partnership with Parkinsons.me and Different Strokes, the event provided a platform for open discussions about the realities of accessing medical cannabis treatment in the UK, the importance of informed patient choice and the role of healthcare professionals in supporting safe and responsible care.
Across panel discussions, expert interviews and audience contributions, one message emerged consistently: although medical cannabis has been legal in the UK since 2018, challenges remain around awareness, access, stigma and the wider patient experience.
The discussions also demonstrated the value of bringing patients, clinicians and industry into the same conversation to identify practical opportunities for progress.
Watch the conversations: Full Beyond Awareness broadcast or explore the individual session recordings on YouTube.
Three key takeaways from the conversation
1. Challenging stigma starts with education
Despite growing awareness of medical cannabis, stigma continues to influence how patients experience treatment and how healthcare professionals approach conversations about cannabis-based medicines.
During the broadcast, Dr Simon Tordoff of CB1 Medical discussed the importance of improving clinical understanding and addressing misconceptions that can prevent patients from having informed conversations about their treatment options.
Participants highlighted the need for greater education and engagement with healthcare professionals, particularly those who may have limited experience of medical cannabis.
Better awareness among clinicians could help patients feel more confident discussing their treatment, while supporting communication between specialist prescribers and other healthcare professionals involved in their care.
Education also has an important role beyond the consulting room. Improving public understanding of the legal status of prescribed medical cannabis and how it is regulated could help address some of the stigma patients continue to encounter.
2. Improving access requires confident clinicians and coordinated care
Access to medical cannabis remains a complex issue, with patients navigating specialist prescribing pathways, treatment costs and varying levels of awareness across the healthcare system.
Discussions explored whether changes to prescribing pathways, including the potential for GPs to play a greater role in initiating treatment in the future, could help improve accessibility.
Dr David Tang of CannPrescribe highlighted the importance of appropriately trained, confident prescribers and well-structured consultations in delivering high-quality patient care.
The conversation also raised wider questions about how medical cannabis treatment could be integrated more effectively into existing healthcare pathways.
Better communication between specialist clinics, GPs and other healthcare professionals could support continuity of care and ensure patients receive appropriate information throughout their treatment journey.
These discussions reinforced the importance of professional education, clear clinical standards and collaboration across healthcare services as the sector continues to develop.
Read Dr David Tang’s reflections on clinical consultations and education.
3. Patient support must extend beyond the prescription
Receiving a prescription does not necessarily mean the challenges experienced by medical cannabis patients come to an end.
Throughout the broadcast, patients and clinicians discussed practical issues affecting everyday life, including treatment affordability, continuing stigma, uncertainty around driving regulations and navigating conversations with healthcare professionals.
These challenges demonstrate why patient support needs to extend beyond prescribing decisions.
Clear guidance, accessible information and ongoing communication can help patients understand their responsibilities and make informed decisions about their treatment.
The discussions also highlighted the importance of ensuring that patients’ lived experiences inform future policy, education and clinical practice.
Patient voices at the centre of the discussion
A particularly valuable aspect of Beyond Awareness was the opportunity for patients to contribute directly to conversations involving clinicians and industry representatives.
Audience questions explored NHS collaboration, research priorities, treatment affordability and the impact of stigma on those prescribed medical cannabis.
The importance of patient involvement was also reflected in feedback shared during the event:
“A big thanks to everyone who has been involved! Nice to see these kind of events where both industry and patients are actively involved.” — Saga, audience feedback via Discord
Feedback from Parkinsons.me also highlighted opportunities to build on these discussions through further engagement with the Parkinson’s community and carers.
These contributions reinforced the importance of listening to patients and ensuring their experiences inform the ongoing development of medical cannabis care in the UK.
Keeping the conversation going
While the broadcast highlighted a number of challenges, it also demonstrated the opportunities that closer collaboration can create.
Improving clinical education, strengthening communication between healthcare professionals, addressing regulatory uncertainty and giving patients a meaningful voice will all be important as the UK medical cannabis sector continues to evolve.
For CIC, bringing these different perspectives together forms part of its broader commitment to supporting a safe, professional and well-regulated industry, advancing evidence-based policy and improving patient access.
The conversations started during Beyond Awareness should continue beyond the event itself, helping inform future engagement, education and collaborative initiatives across the sector.
Watch the Beyond Awareness recordings
For those who missed the live broadcast, or would like to revisit particular discussions, recordings are available on CIC’s YouTube channel.
The programme explores patient perspectives, the role of clinicians, responsible prescribing, patient safety, support beyond the prescription and the wider medical cannabis supply chain.
Watch the full Beyond Awareness broadcast or browse the individual session recordings.
We encourage members, healthcare professionals, patient organisations and other stakeholders to watch and share these conversations to help extend their reach.
Thank you to our partners and supporters
CIC would like to thank our charity partners, Parkinsons.me and Different Strokes, for their involvement and contributions to the broadcast.rtfhjy
We are also grateful to our sponsors, SOMAÍ, Aqualabs, Curaleaf and 4C Labs, and to BRITISH CANNABIS for hosting the event.
Finally, thank you to every speaker, patient, contributor and audience member who helped make Beyond Awareness an open and constructive conversation about the future of medical cannabis care.
